PL369889A1 - Substancje antycholinergiczne, sposób ich wytwarzania oraz ich zastosowanie jako środki lecznicze - Google Patents

Substancje antycholinergiczne, sposób ich wytwarzania oraz ich zastosowanie jako środki lecznicze

Info

Publication number
PL369889A1
PL369889A1 PL03369889A PL36988903A PL369889A1 PL 369889 A1 PL369889 A1 PL 369889A1 PL 03369889 A PL03369889 A PL 03369889A PL 36988903 A PL36988903 A PL 36988903A PL 369889 A1 PL369889 A1 PL 369889A1
Authority
PL
Poland
Prior art keywords
medicaments
producing
same
anticholinergic agents
anticholinergic
Prior art date
Application number
PL03369889A
Other languages
English (en)
Other versions
PL211064B1 (pl
Inventor
Georg Speck
Christian Eickmeier
Sabine Pestel
Sabine Germeyer
Michael P. Pieper
Steffen Breitfelder
Matthias Grauert
Original Assignee
Boehringer Ingelheim Pharma Gmbh & Co.Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma Gmbh & Co.Kg filed Critical Boehringer Ingelheim Pharma Gmbh & Co.Kg
Publication of PL369889A1 publication Critical patent/PL369889A1/pl
Publication of PL211064B1 publication Critical patent/PL211064B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PL369889A 2002-01-31 2003-01-21 Substancje antycholinergiczne, ich zastosowanie,preparaty farmaceutyczne je zawierające oraz związki pośrednie PL211064B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10203749A DE10203749A1 (de) 2002-01-31 2002-01-31 Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel

Publications (2)

Publication Number Publication Date
PL369889A1 true PL369889A1 (pl) 2005-05-02
PL211064B1 PL211064B1 (pl) 2012-04-30

Family

ID=27588163

Family Applications (1)

Application Number Title Priority Date Filing Date
PL369889A PL211064B1 (pl) 2002-01-31 2003-01-21 Substancje antycholinergiczne, ich zastosowanie,preparaty farmaceutyczne je zawierające oraz związki pośrednie

Country Status (20)

Country Link
EP (1) EP1472250B1 (pl)
JP (1) JP4484521B2 (pl)
KR (1) KR100950870B1 (pl)
CN (1) CN1291986C (pl)
AR (1) AR038331A1 (pl)
AU (1) AU2003206760B8 (pl)
BR (1) BR0307299A (pl)
CA (1) CA2474874C (pl)
CO (1) CO5601000A2 (pl)
DE (1) DE10203749A1 (pl)
IL (1) IL162669A0 (pl)
MX (1) MXPA04007249A (pl)
NZ (1) NZ534927A (pl)
PE (1) PE20030964A1 (pl)
PL (1) PL211064B1 (pl)
RU (1) RU2325388C2 (pl)
TW (1) TWI260323B (pl)
UY (1) UY27629A1 (pl)
WO (1) WO2003064418A1 (pl)
ZA (1) ZA200404569B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004206846B2 (en) * 2003-01-16 2009-05-28 University Of Rochester Quaternary antimuscarinic compounds for the treatment of bladder diseases
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
US7507745B2 (en) 2004-02-20 2009-03-24 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on fluorenecarboxylic acid esters and soluble TNF receptor fusion proteins
WO2005079794A1 (en) * 2004-02-20 2005-09-01 Boehringer Ingelheim International Gmbh Pharmaceutical compositions based on anticholinergics and pegsunercept
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
ES2322148T3 (es) * 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20080027094A1 (en) * 2004-08-30 2008-01-31 Ono Pharmaceutical Co., Ltd. Tropane Compounds and Pharmaceutical Compositions Comprising the Same as an Active Ingredient
EP1855689A1 (en) * 2005-02-16 2007-11-21 Boehringer Ingelheim International GmbH Pharmaceutical compositions comprising anticholinergics and etiprednol
CA2600636A1 (en) * 2005-03-09 2006-09-14 Boehringer Ingelheim International Gmbh New pharmaceutical compositions based on anticholinergics and pde 5-inhibitors
CA2609429A1 (en) * 2005-05-31 2006-12-07 Boehringer Ingelheim International Gmbh Medicament containing a betamimetic in conjunction with an anticholinergic and a pde iv inhibitor
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
JP2009091250A (ja) * 2006-01-30 2009-04-30 Ono Pharmaceut Co Ltd トロパン化合物およびそれらを有効成分として含有する医薬組成物
CA2660186A1 (en) 2006-08-07 2008-02-14 Boehringer Ingelheim International Gmbh Pharmaceutical combinations for the treatment of respiratory diseases
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
ES2569359T3 (es) 2007-07-06 2016-05-10 Vectura Delivery Devices Limited Inhalador
EP2180892A2 (en) * 2007-07-18 2010-05-05 Boehringer Ingelheim International GmbH Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma
EP2082768A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082772A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082771A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082767A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Inhaler
EP2082766A1 (en) 2008-01-24 2009-07-29 Vectura Delivery Devices Limited Blister Strip Coil Forming
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
GB0918450D0 (en) 2009-10-21 2009-12-09 Innovata Ltd Composition
RU2535027C2 (ru) * 2012-08-10 2014-12-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт экспериментальной медицины" Северо-Западного отделения Российской академии медицинских наук (ФГБУ "НИИЭМ" СЗО РАМН) Антидепрессивное средство
CN102964345B (zh) * 2012-12-06 2016-07-13 四川理工学院 一种2―羟基―2,2―二苯基乙酸―3α―(8―氮杂双环[3,2,1])―3―辛酯的制备方法
BR112018010347A2 (pt) 2015-11-23 2018-12-04 Syngenta Participations Ag derivados heterocíclicos ativos em termos pesticidas com substituintes contendo enxofre e ciclopropila
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
BR112020006677A2 (pt) 2017-10-05 2020-10-06 Fulcrum Therapeutics, Inc. uso de inibidores p38 para reduzir a expressão de dux4

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE4108393A1 (de) * 1991-03-15 1992-09-17 Boehringer Ingelheim Kg Neue ester bi- und tricyclischer aminoalkohole, ihre herstellung und ihre verwendung in arzneimitteln

Also Published As

Publication number Publication date
MXPA04007249A (es) 2004-10-29
AU2003206760B2 (en) 2009-03-26
WO2003064418A1 (de) 2003-08-07
ZA200404569B (en) 2006-08-30
IL162669A0 (en) 2005-11-20
CO5601000A2 (es) 2006-01-31
CN1291986C (zh) 2006-12-27
KR20040081168A (ko) 2004-09-20
RU2325388C2 (ru) 2008-05-27
TWI260323B (en) 2006-08-21
CN1625556A (zh) 2005-06-08
JP2005525323A (ja) 2005-08-25
NZ534927A (en) 2006-10-27
PL211064B1 (pl) 2012-04-30
AU2003206760B8 (en) 2009-05-07
CA2474874C (en) 2012-10-30
DE10203749A1 (de) 2003-08-14
EP1472250B1 (de) 2014-11-26
EP1472250A1 (de) 2004-11-03
KR100950870B1 (ko) 2010-04-06
TW200404800A (en) 2004-04-01
HK1077818A1 (en) 2006-02-24
CA2474874A1 (en) 2003-08-07
UY27629A1 (es) 2003-08-29
JP4484521B2 (ja) 2010-06-16
RU2004126441A (ru) 2005-07-10
PE20030964A1 (es) 2003-12-24
AR038331A1 (es) 2005-01-12
BR0307299A (pt) 2004-12-21

Similar Documents

Publication Publication Date Title
PL369889A1 (pl) Substancje antycholinergiczne, sposób ich wytwarzania oraz ich zastosowanie jako środki lecznicze
AU2003206760A1 (en) Anticholinergic agents, method for producing the same and use thereof as medicaments
IL160440A (en) Dihydropteridinones, method for producing the same and the use thereof as medicaments
AU2002337047A1 (en) Novel dihydropteridinones, method for producing the same and the use thereof as medicaments
PL378065A1 (pl) Podstawione związki N-aryloheterocykliczne, sposób ich wytwarzania oraz ich zastosowanie jako środków leczniczych
PL376373A1 (pl) Wybrani antagoniści CGRP, sposoby ich wytwarzaniai ich zastosowanie jako leki
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
IL168056A0 (en) Selected cgrp antagonists, method for production and use thereof as medicament
AU2002213977A1 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
IL155334A0 (en) Novel anticholinergic agents that can be used as medicaments and method for the production thereof
HRP20031066A2 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
IL181012A0 (en) Substituted 8-aminoalkoxi-xanthines, method for the production thereof and use thereof as medicaments
PL376399A1 (pl) Nowe związki pirydopirymidynowe, proces ich wytwarzania i zawierające je mieszanki farmaceutyczne
IL162316A0 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition t
IL161893A0 (en) 5-Phenylpyrimidines, agents comprising the same, method for production and use thereof
AU2003271185A1 (en) Imidazopyridine derivative, process for producing the same, and use
PL371784A1 (pl) Pentafluorotio-benzoiloguanidyny, sposób ich wytwarzania, ich zastosowanie jako środka leczniczego lub diagnostycznego oraz środek leczniczy zawierający te związki
ZA200500526B (en) Prodrug, medicinal utilization thereof and process for producing the same
EP1561434A4 (en) BITE ATTACHMENT, BIT AND MANUFACTURING PROCESS THEREFOR
EP1582589A4 (en) PROTEIN COMPLEX, METHOD FOR THE PRODUCTION AND USE THEREOF
IL174975A0 (en) 2-phenyl-benzofuran derivatives, method for the production thereof and their use
ZA200601001B (en) Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicament comprising the same
IL157793A0 (en) Caloporoside derivatives, methods for the production thereof and their use